Integration of innate and adaptive immunity in transplantation.
Michel Goldman
14th NAT - Innate immunity and inflammation in transplantation
Nantes, June 2008

Voies non conventionnelles du rejet d'allogreffe : implication pour les essais cliniques d'induction de tolérance.
Michel Goldman
8èmes rencontres de Beaune - Recherche en Transplantation
Beaune, June 2008

Facing new challenges in transplantation research : the need for innovative partnerships.
Michel Goldman
Roche event "Optimizing the treatment continuum in chronic kideny disease patients"
Bruxelles, April 2008

Tolerance induction in clinical transplantation.
Michel GOLDMAN
22nd European Immunogenetics and Histocompatibility Conference
Toulouse, April 2008

A reassessment of cellular mechanisms underlying graft rejection.
Michel GOLDMAN
World Immune Regulation Meeting
Davos, March 2008

Hurdles to vaccination in early life: revisiting immunological immaturity in human newborns.
Michel GOLDMAN
Vaccinology course
Paris, March 2008

Auto-immunity and tolerance.
Michel GOLDMAN
Joint Meeting of the Royal Society of Medicine, the French Society of Nephrology and the UK Renal Association
London, February 2008

Toll-like-receptor ligands as immune modifiers.
Michel GOLDMAN
8th International Conference on New Trends in Immunosuppression and Immunotherapy
Berlin, February 2008

Regulation of autoimmune and alloimmune responses: the complexity is growing.
Michel GOLDMAN
Centre for Immunology Amsterdam Opening Symposium
Amsterdam, February 2008

The impact of immunosuppression on the status of tolerance in kidney transplant recipients.
Michel GOLDMAN
II jornada de inmunosupresion clinica y experimental en trasplantes
Barcelona, January 2008

Les multiples formes du rejet d'allogreffe: nouveaux obstacles pour l'induction de tolerance en transplantation clinique.
Michel GOLDMAN
7ème Congrès Annuel de la Société de Transplantation
Lyon, December 2007

The growing complexity of immunoregulatory circuits: relevance to novel immunotherapies.
Michel GOLDMAN
Univesrity of Bern Department of Clinical Research
Bern, November 2007

Les cytokines de la famille de l'interleukine-12: nouvelles cibles thérapeutiques.
Michel GOLDMAN
Academy of Immunology for Clinicians
Brussels, November 2007

Faut-il craindre les vaccins?
Michel GOLDMAN
Conférence-déjeuner des Femmes Réformatrices
Brussels, November 2007

Transplantation tolerance in the clinic: how to overcome the multiple hurdles?
Michel GOLDMAN
Eurpean School of Haematology Conference on Translational Research in Transplantation
Leiden, November  2007

The added value of research networks in transplantation.
Michel GOLDMAN
13th European Society for Organ Transplantation Congress
Prague, October 2007

The roadmap to transplantation tolerance in the clinic: opportunities and hurdles.
Michel GOLDMAN
37th annual meeting of the German Society of Immunology
Heidelberg, September 2007

Mécanisme d'action du CTLA4-Ig.
Alain LE MOINE
Réunion conjointe des Sociétés Francophone de Néphrologie et de Dialyse
Lyon, September 2007

Hypereosinophilic syndrome: new therapeutic options.
Florence ROUFOSSE
39th Annual Advanced Course in Haematology
London, September 2007

Pathogenic variants of hypereosinophilic syndrome: definition and clinical applications.
Florence ROUFOSSE
British Society for Allergy and Clinical Immunology Annual Meeting
Loughborough, July 2007

Immune tolerance network.
Michel GOLDMAN
7èmes Rencontres de Beaune - Recherche en Transplantation
Beaune, June 2007

Systemic sclerosis : an auto-immune or allo-immune disorder?
Florence ROUFOSSE
Congrès National d'Asthme et d'Allergie
Paris, June 2007

Differential regulation of IL-12 family members downstream of Toll-like receptors: relevance to neonatal immunity.
Michel GOLDMAN
Seminar of the University of Lisbon Medical School
Lisbon, May 2007

Novel therapeutic strategies and biomarkers stem from basic research: the example of hypereosinophilic syndromes.
Florence ROUFOSSE
10ème colloque Cytokines du Croisic
Croisic, May 2007

Immunosénescence et transplantation.
Alain LE MOINE
Groupe de Venise
Madeira, March 2007

Current European research initiatives
Michel GOLDMAN
Molecular signatures in transplantation tolerance
Madrid, March 2007

What's new in stem cell transplantation?
Michel GOLDMAN
British Society of Immunology Congress
Glasgow, February 2007

From tolerance to auto-immunity : is there a risk in early-life vaccination?
Michel GOLDMAN
Merial Vaccinology Symposium
Athens, November 2006

Antigen presentation, dendritic cells.
Michel GOLDMAN
European Society for Organ Transplantation - Hesperis Course
Lyon, November 2006

Monitoring of allogeneic responses.
Alain LE MOINE
European Transplantation-Course Hesperis
Lyon, November 2006

Tolerance induction, animal models.
Alain LE MOINE
European Transplantation-Course Hesperis
Lyon, November 2006

Cellular immunity to CMV during foetal life.
Arnaud MARCHANT
Conference on Congenital CMV infection
Orvieto, November 2006

La tolérance aux allogreffes : comment convertir la découverte en innovation?
Michel GOLDMAN
Réunion conjointe des Sociétés Francophones de Néphrologie et de Dialyse
Lille, October 2006

Transplantation tolerance : where we are?
Michel GOLDMAN
European Renal Association
Continuous Medical Education Conference
Rome, October 2006

Activation et cibles antigéniques des lymphocytes B en transplantation.
Alain LE MOINE
Société Française de Néphrologie
Lille, October 2006

Anti-Interleukin-5 antibody in eosinophilic disorders.
Florence ROUFOSSE
16th European Congress of Immunology
Paris, September 2006

Dendritic cell responses in human newborns.
Fabienne WILLEMS
1st Joint Meeting of European National Society of Immunology, 16th European Congress of Immunology
Paris, September 2006

Alternative mechanisms of cellular rejection.
Michel GOLDMAN
World Transplant Congress
Boston, July 2006

Regulation of DC function by Treg cells.
Michel BRAUN
Séminaires internes de l'INSERM U563
Toulouse, June 2006

Clinically applicable strategies to induce transplantation tolerance.
Michel GOLDMAN
7th International Conference on Immunosuppression
Berlin, February 2006

Immune suppression induced by bacterial superantigen.
Michel BRAUN
Séminaires internes du Laboratoire d'Immunologie
Université de Montréal, February 2006

Properties of dendritic cells in human newborns.
Fabienne WILLEMS
Seminar at the Instituto Gulbenkian de Ciencia
Oeiras Portugal, February 2006

Tolerance induction strategies in organ and cell transplantation.
Michel GOLDMAN
BetaCell Therapy Symposium
Brussels, January 2006

Reprogramming the Immune System for the Establishment of Tolerance.
Michel GOLDMAN
Joint meeting of the Juvenile Diabetes Research Foundation and the Research Directorate of the European Commission
Brussels, December 2005 

Innate immunity in transplantation biology.
Michel GOLDMAN
Hesperis course
Vienna, November 2005

Stem cell transplantation, animal models and clinical trials.
Alain LE MOINE
European Transplantation-Course Hesperis
Vienna, November 2005

Immunosénescence en transplantation.
Alain LE MOINE
5ème congrès de la Société Francophone de Transplantation
Tours, November 2005

Voies d'activation dans l'ischémie-reperfusion.
Alain LE MOINE
5ème congrès de la Société Francophone de Transplantation
Tours, November 2005

Experimental models of tolerance induction.
Alain LE MOINE
European Transplantation-Course Hesperis
Vienna, November 2005

T lymphocyte response to human cytomegalovirus in early life.
Arnaud MARCHANT
Séminaire de l'Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire
Brussels, November 2005

Dendritic cells in early life.
Fabienne WILLEMS
Annual Congress of the French Immunology Society and Francophone Club of Dendritic Cells
Toulouse, November 2005

Translating transplantation tolerance in the clinic : new hopes and new barriers.
Michel GOLDMAN
12th congress of the European Society for Organ Transplantation
Geneva, October 2005

The role of innate immunity in type 1 diabetes and the rejection of islet allografts.
Michel GOLDMAN
41st European Association for the Study of Diabetes
Athens, September 2005

Early events governing transplant rejection : new challenges for tolerance induction in the clinic.
Michel GOLDMAN
European Renal Association XLII Congress
Istanbul, June 2005

Dendritic cells in human newborns : keys to deficient Th1 responses in early life?
Michel GOLDMAN
European Network of Immunology Institutes
Ile des Embiez, May 2005

Tolerance in organ transplantation: rationale and barriers.
Vincent DONCKIER
Le cellule staminali : La grande promessa della medicina dei prossimi anni
Napoli, May 2005 

T lymphocyte response to human cytomegalovirus infection during fetal life.
Arnaud MARCHANT
European Network of Immunology Institutes
Ile des Embiez, May 2005

Immunoregulatory molecules for treatment of hypereosinophilic syndromes.
Florence ROUFOSSE
NIH-funded Hypereosinophilic Syndrome Workshop
Bern, May 2005

The lymphocytic variant of hypereosinophilic syndromes.
Florence ROUFOSSE
4th Biennial Congress of the International Eosinophil Society
Bern, May 2005

Pathobiologic mechanisms in rejection.
Michel GOLDMAN
First Annual Forum on Immunological Pathways in Transplantation
Madrid, April 2005

The importance of innate immunity in transplantation.
Michel GOLDMAN
The Royal Society of Medicine
London, March 2005

On the way to specific immune tolerance.
Michel GOLDMAN
29th Nephrology Seminar
Heidelberg, March 2005

Ontogeny and function of dendritic cells.
Michel GOLDMAN
Frontiers in Neonatal and Infant Immunity
Madrid, March 2005

Stem cells for tolerance induction in liver transplantation.
Vincent DONCKIER
Transplant Immunology: new frontiers
Ghent, March 2005

Characterization and potential clinical application of Stem Cells in transplantation.
Alain LE MOINE
Prospettive terapeutiche e dubbi bioetici Due giorni di studi e riflessioni tra esperti e addetti ai lavori
Napoli, March 2005

Antigen-specific T cell responses in neonates.
Arnaud MARCHANT
Frontiers in Neonatal and Infant Immunity
Madrid, March 2005

Les lymphocytes régulateurs en transplantation.
Alain LE MOINE
Séminaires internes de l'Hôpital du Kremlin Bicêtre
Paris, January 2005

The multiple pathways to allograft rejection.
Michel GOLDMAN
Transplant Asia
Singapore, December 2004

Stem cells as inducers of transplantation tolerance.
Michel GOLDMAN
Transplant Asia
Singapore, December 2004

Multiple pathways to allograft rejections.
Alain LE MOINE
3rd International Congress on Immunosuppression
San Diego, December 2004

Cytokine redundancy : IL-9 and rejection.
Michel BRAUN
European Society for Organ Transplantation, Hesperis Course
Rotterdam, November 2004

Regulatory T-cells and super-antigen induced tolerance.
Michel BRAUN
European Society for Organ Transplantation, Hesperis Course
Rotterdam, November 2004

Synopsis sur les lymphocytes régulateurs.
Alain LE MOINE
4ème Congrés de la Société Francophone de Transplantation
Brussels, November 2004

Activation des lymphocytes T en transplantation.
Michel GOLDMAN
Club de la Transplantation
Chantilly, October 2004

Dendritic cells in human newborns.
Michel GOLDMAN
8th International Symposium on Dendritic Cells
Brugge, October 2004

Les mécanismes de destruction de greffes en absence de reconnaissance directe de la greffe par les lymphocytes T.
Michel BRAUN
4ème Congrès de la Société Francophone de Transplantation
Brussels, October 2004

Enjeux de l'induction d'un état de tolérance en transplantation.
Alain LE MOINE
Séminaires de l'Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire
Brussels, October 2004

Dendritic cell responses in human newborns.
Fabienne WILLEMS
Joint Annual Meeting of the Dutch and German Societies
Maastricht, October 2004

Mechanisms of graft destruction in the absence of cognate recognition between the graft and T cells.
Michel BRAUN
XXth International Congress of the Transplantation Society
Vienna, September 2004

Biomedicine in the European research area : how to promote translational research?
Michel GOLDMAN
New Therapies and Medicines stemming from Genomics and Biotechnology
Aguadulce, July 2004

The multiple pathways to transplant rejection.
Michel GOLDMAN
Plenary Lecture
Joint Meeting of the Italian Societies of Immunology and Nephrology
May 2004

Les réseaux internationaux de recherche dédiés à la transplantation.
Michel GOLDMAN
Célébration de la 3000ème greffe rénale au CHU de Nantes
Nantes, May 2004

Induction of Tolerance in Living Related Liver Transplantation.
Vincent DONCKIER
Asian Medical Center
Seoul, May 2004

Induction of Tolerance in Living Related Liver Transplantation.
Vincent DONCKIER
Kyoto Faculty of Medecine
Kyoto, May 2004

Towards transplantation tolerance : a need for new partnerships
Keynote Plenary Lecture.
Michel GOLDMAN
Annual Meeting of the British Transplant Society
Birmingham, April 2004

Le rôle des cellules endothéliales du receveur dans le rejet de greffe vascularisée.
Michel BRAUN
Séminaires Transatlantiques de l'Institut de Recherche en Immunovaccinologie et Cancérologie de l'Université de Montréal et de l'Institut d'Immunologie Médicale
Parentville, April 2004

Induction de tolérance aux allogreffes d'organes solides à l'aide de cellules souches hématopoïétiques
Michel GOLDMAN
1ères Actualités et Développements en Néphrologie
Paris, March 2004

Tolerance at the frontier of clinical application: challenges of translational research in Europe.
Michel GOLDMAN
New Trends in Immunosuppression
Salzburg, February 2004

A dual role for dendritic cells in transplantation immunity.
Michel GOLDMAN
Basic Science Symposium on Chronic Renal Allograft Nephropathy
Heidelberg, February 2004

Tolerance to microbial superantigens and its role in immune responses.
Michel BRAUN
Séminaires internes de l'Institut Pasteur
Brussels, January 2004